Product — Revenue
Pfizer Product — Revenue increased by 3.7% to $11.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.7%, from $11.29B to $11.72B. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration, strong clinical demand, or effective commercial execution for that specific product. A decrease may signal patent expirations, increased generic competition, or shifting clinical treatment guidelines.
Detailed definition
This metric represents the total gross sales generated from a specific pharmaceutical product line or therapeutic catego...
Peer comparison
Comparable to product-level revenue disclosures in other large-cap pharmaceutical companies, often categorized by therapeutic area such as oncology, immunology, or vaccines.
pfe_segment_product_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $147.50M | $147.50M | $147.50M | $11.29B | $11.72B |
| QoQ Change | — | +0.0% | +0.0% | >999% | +3.7% |
| YoY Change | — | — | — | — | +3.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Pfizer's product — revenue?
- Pfizer (PFE) reported product — revenue of $11.72B in Q1 2026.
- How has Pfizer's product — revenue changed year-over-year?
- Pfizer's product — revenue increased by 3.7% year-over-year, from $11.29B to $11.72B.
- What does product — revenue mean?
- The total revenue earned from the sales of a specific pharmaceutical product or drug category.